Elizabeth Lucas, DO
Family Medicine · Middlesboro, KYNPI 1346524154
Payments from drug & device makers
Across 107 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$429
- Lilly USA, LLC$367
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$188
- AstraZeneca$184
- Merck$80
- Amgen$72
- plus $423 from 12 others
What the payments were for
- Food & beverage$1,63094%
- Education$1136%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $429 |
| Lilly USA, LLC | 26 | $367 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $188 |
| AstraZeneca | 11 | $184 |
| Merck | 6 | $80 |
| Amgen(2 entities) | 4 | $72 |
| Astellas Pharma US Inc | 1 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Boehringer Ingelheim | 3 | $45 |
| Pfizer | 2 | $42 |
| Mylan Specialty L.p. | 2 | $32 |
| Novartis | 2 | $30 |
| Bayer | 2 | $30 |
| Alkermes, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| VBI Vaccine (delaware) Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $12 |
How this compares
$1,743 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 57 | $72,715 |
| TrulicityDulaglutide | 38 | $47,904 |
| JardianceEmpagliflozin | 48 | $46,011 |
| EliquisApixaban | 50 | $45,508 |
| OzempicSemaglutide | 42 | $45,350 |
| FarxigaDapagliflozin Propanediol | 47 | $33,672 |
| VraylarCariprazine Hcl | 24 | $33,048 |
| EntrestoSacubitril/Valsartan | 18 | $26,060 |
| XareltoRivaroxaban | 17 | $16,655 |
| LinzessLinaclotide | 15 | $13,773 |
| Spiriva HandihalerTiotropium Bromide | 19 | $13,545 |
| JanuviaSitagliptin Phosphate | 11 | $12,343 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $12,279 |
| Repatha SyringeEvolocumab | 11 | $9,926 |
| Levemir FlexpenInsulin Detemir | 23 | $6,778 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $367 | $120,61995 claims |
| AbbVieVraylar, Linzess | $429 | $46,82239 claims |
| Boehringer IngelheimJardiance | $45 | $46,01148 claims |
| PfizerEliquis | $42 | $45,50850 claims |
| AstraZenecaFarxiga | $184 | $33,67247 claims |
| NovartisEntresto | $30 | $26,06018 claims |
| MerckJanuvia | $80 | $12,34311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Middlesboro
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.